CN Patent

CN109476686B — sGC刺激剂的磷前药

Assigned to Cyclone Therapy Co Ltd · Expires 2022-01-18 · 4y expired

What this patent protects

本专利申请公开了如下所示的式I化合物或其药学上可接受的盐，其中J B ，n，R 1 ，R 2 ，R 3 ，R 4 ，R 5 ，m和X如本文所定义。

USPTO Abstract

本专利申请公开了如下所示的式I化合物或其药学上可接受的盐，其中J B ，n，R 1 ，R 2 ，R 3 ，R 4 ，R 5 ，m和X如本文所定义。

Drugs covered by this patent

Adempas (RIOCIGUAT) · Bayer

Patent Metadata

Patent number: CN109476686B
Jurisdiction: CN
Classification: —
Expires: 2022-01-18
Drug substance claim: No
Drug product claim: No
Assignee: Cyclone Therapy Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.